This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Feb. 17, 2014 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) (the "Company") today announced its plan to release financial results for the third quarter and first nine months of fiscal year 2014 on
Monday, February 24, 2014, after the markets close in the U.S.
The Company will host a conference call at
8:00 a.m. ET on
Tuesday, February 25, 2014 to discuss its financial performance and give a brief overview of the Company's recent developments, followed by a question and answer session. Interested parties may access the audio webcast through the Company's IR website at
http://ir.chinacordbloodcorp.com. A replay of the webcast will be accessible two hours after the conference call and available for three weeks at the same URL link above. Listeners may also access the call by dialing 1-631-514-2526 or 1-855-298-3404 for US callers or +852-5808-3202 for
Hong Kong callers, access code: 2926250.
Please dial in ten minutes prior to the conference call to ensure proper connection, and be prepared to provide your name and company name to the operator.
Supplemental financial information referenced in the conference call and the third quarter of fiscal 2014 earnings press release will be available at
http://www.chinacordbloodcorp.com, in the section titled Investor Center/Press Release, after
4:00 p.m. ET on
Monday, February 24, 2014 and in the Company's Report on Form 6-K for the month of
February 2014 available on the Securities and Exchange Commission's website at
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical cord blood banking operator in
China in terms of geographical coverage and the only cord blood banking operator with multiple licenses. Under current PRC government regulations, only one licensed cord blood banking operator is permitted to operate in each licensed region and only seven licenses have been authorized as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. For more information, please visit the Company's website at
For more information, please contact:
China Cord Blood CorporationInvestor Relations DepartmentTel: (+852) 3605-8180Email:
William ZimaTel: (+86) 10-6583-7511U.S. Tel: (646) 405-5185Email:
SOURCE China Cord Blood Corporation